These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16193101)

  • 1. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cripto: a novel target for antibody-based cancer immunotherapy.
    Xing PX; Hu XF; Pietersz GA; Hosick HL; McKenzie IF
    Cancer Res; 2004 Jun; 64(11):4018-23. PubMed ID: 15173016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto as a target for cancer immunotherapy.
    Hu XF; Xing PX
    Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cripto-1 as a target for a cancer vaccine: WO2008040759.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2009 Feb; 19(2):141-4. PubMed ID: 19441915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrypting the role of Cripto in tumorigenesis.
    Shen MM
    J Clin Invest; 2003 Aug; 112(4):500-2. PubMed ID: 12925690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
    Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
    Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
    Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
    Calvanese L; Saporito A; Oliva R; D' Auria G; Pedone C; Paolillo L; Ruvo M; Marasco D; Falcigno L
    J Pept Sci; 2009 Mar; 15(3):175-83. PubMed ID: 19035567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
    Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
    Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
    J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells.
    Wechselberger C; Ebert AD; Bianco C; Khan NI; Sun Y; Wallace-Jones B; Montesano R; Salomon DS
    Exp Cell Res; 2001 May; 266(1):95-105. PubMed ID: 11339828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.
    Minchiotti G
    Oncogene; 2005 Aug; 24(37):5668-75. PubMed ID: 16123800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Cripto-1 protein in development and target therapy of breast cancer].
    Lei T; Guo XJ; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):66-8. PubMed ID: 20388407
    [No Abstract]   [Full Text] [Related]  

  • 19. CRIPTO3, a presumed pseudogene, is expressed in cancer.
    Sun C; Orozco O; Olson DL; Choi E; Garber E; Tizard R; Szak S; Sanicola M; Carulli JP
    Biochem Biophys Res Commun; 2008 Dec; 377(1):215-20. PubMed ID: 18835250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto-1: an oncofetal gene with many faces.
    Bianco C; Strizzi L; Normanno N; Khan N; Salomon DS
    Curr Top Dev Biol; 2005; 67():85-133. PubMed ID: 15949532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.